Antifungal therapy in the management of chronic candidiasis.
The most pathogenic Candida species are identified and the structure of imidazole compounds and their mechanism of action on yeast cells are described. Not all yeast species react in the same way to imidazole preparations, and these actions are documented.
Horowitz
B J
BJ
Department of Obstetrics and Gynecology, Mt. Sinai Hospital, Hartford, CT.
D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002175:Candida / Q000187:drug effects; D002176:Candida albicans / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use
D000935:Antifungal Agents; D007093:Imidazoles; D011743:Pyrimidines; C017125:butoconazole